insights_auto
Por qué ha bajado 603259 6,60%?
Profundizarchevron_right
603259:SHA
WuXi AppTec Co Ltd
144,30 CNY
arrow_downward
-6,60%(-10,20) 1 d
16 oct, 15:00:01 GMT+8 · CNY
search
Todos los símbolos
| Símbolo | Precio | Cambio | % de cambio |
|---|
insights_autoGenerando estadísticas principales de 603259...
Abrir
156,94 CNY
Alto
159,92 CNY
Bajo
139,05 CNY
Cap. burs.
484,94 mil M
Vol. medio
34,02 M
Volumen
83,61 M
Dividendo
1,45 %
Dividendo trimestral
0,52 CNY
Fecha exdividendo
4 sept 2026
Ratio PER
19,63
Máximo en 52 sem.
173,60 CNY
Mínimo en 52 sem.
87,09 CNY
BPA
7,35 CNY
Acciones en circulación
1048,27 M
N.º de empleados
36 mil
Abrir
156,94 CNY
Alto
159,92 CNY
Bajo
139,05 CNY
Cap. burs.
484,94 mil M
Vol. medio
34,02 M
Volumen
83,61 M
Dividendo
1,45 %
Dividendo trimestral
0,52 CNY
Fecha exdividendo
4 sept 2026
Ratio PER
19,63
Máximo en 52 sem.
173,60 CNY
Mínimo en 52 sem.
87,09 CNY
BPA
7,35 CNY
Acciones en circulación
1048,27 M
N.º de empleados
36 mil
Noticias
De fuentes web y partners de noticias
ad-hoc-news.de
·
hace 52 minutos
Morgan Stanley keeps target for WuXi AppTec stock at HKD 207.40
ad-hoc-news.de
·
hace 1 día
Morgan Stanley backs 800-ton expansion for WuXi AppTec stock
ad-hoc-news.de
·
hace 1 día
Morgan Stanley keeps HKD 207.40 target for WuXi AppTec stock
ad-hoc-news.de
·
hace 2 días
Huaxi Securities maintains Buy for WuXi AppTec stock
Perfil
WuXi AppTec Co., Ltd. is a Chinese provider of contract research, development, and manufacturing, services for the pharmaceutical and life-sciences industry, headquartered in Shanghai, China. The company operates research and manufacturing facilities in Asia, North America, and Europe.
Founded in 2000 by chemist Ge Li as WuXi PharmaTech, the company expanded through acquisitions and re‑listings in 2018 after a 2015 take‑private. It produces a large part of the ingredients used in treatments for illnesses including leukemia, lymphoma, HIV, and obesity. As of 2025, the company reported around 39,000 employees and 6,000 customers. Its clients have included Jiangsu Hengrui, GlaxoSmithKline, AstraZeneca and Pfizer. Wikipedia
Acerca de WuXi AppTec Co Ltd